Amphastar Pharmaceuticals AMPH Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.42M-73.7% | $24.43M+40.8% | $17.35M-44.1% | $31.03M+22.7% | $25.29M-33.4% | ||
| $8.08M+0.1% | $8.07M+2.7% | $7.86M-5.8% | $8.35M+13.3% | $7.37M+1.5% | ||
| $9.27M+49.5% | $6.21M-1.5% | $6.3M-1.3% | $6.38M-24.0% | $8.39M+49.0% | ||
| $47.84M+45.6% | $32.86M-37.5% | $52.58M+47.7% | $35.59M+1.5% | $35.08M+20.9% | ||
| $9.51M+14.9% | $8.27M+54.7% | $5.35M-49.4% | $10.57M-1.2% | $10.7M-13.8% | ||
| -$16.73M+72.4% | -$60.57M-209% | -$19.62M-3,039% | -$625K-106% | $10.48M+129% | ||
| $29.49M+43.8% | $20.52M+323% | $4.85M-87.6% | $39.22M+257% | $11M-73.8% | ||
| —— | —— | $172K-95.8% | $4.13M+151% | $1.64M— | ||
| $29K-72.1% | $104K+136% | $44K+18.9% | $37K-2.6% | $38K-67.0% | ||
| -$30.21M-64.4% | -$18.37M-323% | -$4.35M+85.6% | -$30.2M-108% | -$14.5M+57.1% | ||
| $762K— | —— | $28.58M+482% | $4.91M-84.3% | $31.17M— | ||
| $38.33M+55.9% | $24.59M-47.9% | $47.24M+88.7% | $25.03M+2.7% | $24.38M+46.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Amphastar Pharmaceuticals generate?
- Amphastar Pharmaceuticals (AMPH) generated $168.9M in operating cash flow over the trailing twelve months.
- What is Amphastar Pharmaceuticals's free cash flow?
- After $33.7M of capital expenditures, Amphastar Pharmaceuticals's free cash flow was $135.2M over the trailing twelve months, down 10.0% year over year.
- Where does Amphastar Pharmaceuticals's cash flow data come from?
- Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
